Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease

Meghan Martin1, Brian H Wrotniak1, Mark Hicar1

  • 1Department of Pediatrics, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, United States of America.

Plos One
|March 27, 2018
PubMed

Insights

Infants show reduced plasmablast responses, similar in Kawasaki disease (KD) and controls. This suggests an infectious link to KD, but further infant immune studies are needed.

Area of Science:

  • Pediatric immunology
  • Infectious diseases
  • B cell biology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children, predominantly affecting infants and toddlers.
  • Understanding infant immune responses is crucial for KD research but remains limited.
  • Plasmablasts, transitional B cells, are key to adaptive immunity, but their role in infants is understudied.

Purpose of the Study:

  • To investigate and compare plasmablast responses in infants and children with Kawasaki disease (KD) versus febrile controls.
  • To explore the role of plasmablasts in the immune response during KD in the predominant age group affected.

Main Methods:

  • Recruited children with suspected KD or overlapping symptoms from a pediatric emergency room.
  • Isolated peripheral blood mononuclear cells and analyzed B cell markers using flow cytometry.
  • Compared plasmablast levels in 18 KD subjects and 69 febrile controls.

Main Results:

  • Plasmablast numbers and temporal patterns were similar between KD subjects and infectious disease controls.
  • Infants in both KD and control groups exhibited diminished plasmablast responses compared to older children.
  • A blunted peripheral plasmablast response was observed in infants during this single-time point survey.

Conclusions:

  • Similar plasmablast responses in KD and controls suggest a potential infectious etiology for KD.
  • Infants demonstrate a generally weaker peripheral plasmablast response, irrespective of KD status.
  • Further longitudinal studies on infant plasmablast kinetics are necessary to understand their contribution to immune responses.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
713
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
976
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.0K
Responses to Gravity and Touch02:26

Responses to Gravity and Touch

Gravitropism: Plant Responses to Gravity
42.0K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
84.1K